Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer.
about
Targeting hypoxia to overcome radiation resistance in head & neck cancers: real challenge or clinical fairytale?The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future.Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy.Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial.Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: Results of the BRANCH trialThe status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers.Long-term oncologic outcomes of neoadjuvant concurrent chemoradiotherapy with capecitabine and radical surgery in locally advanced rectal cancer: 10-year experiences at a single institution.A clinical study of metastasized rectal cancer treatment: assessing a multimodal approach.Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: a systematic review.Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study.The Addition of Target Therapy to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Review.The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta-analysis.
P2860
Q30388849-A42A2956-0218-4816-A5A8-CACB6E145C12Q33705268-9B343172-FD20-4797-8ADE-0EDE562231DBQ34995048-546C8A2E-23C9-49A3-8252-B67E6ED9B346Q35475535-5938F266-5DA7-4D61-9DCA-E232AB178B64Q36557606-2B58268E-D3C0-478B-8B67-F59E42EA2ACDQ37015715-32734093-D8C5-482D-A7C2-75694E543175Q37339474-A29201C8-DC70-4224-8AD9-A16ADB027C11Q37601319-5DBC0C7A-481F-4B87-8ADA-459D0142ECBAQ38216007-144BF83E-D052-4E31-B19C-F3F761651746Q38425364-8ED47C72-EC13-448E-891E-9BB5E3F3AD7EQ39359799-59E7C937-36C2-44A9-9B85-C96BD6D5CDC4Q49718931-0B317D3A-EBA7-4A10-B086-ED8DF97F3206
P2860
Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Phase II trial of preoperative ...... ocally advanced rectal cancer.
@en
type
label
Phase II trial of preoperative ...... ocally advanced rectal cancer.
@en
prefLabel
Phase II trial of preoperative ...... ocally advanced rectal cancer.
@en
P2093
P2860
P921
P356
P1433
P1476
Phase II trial of preoperative ...... ocally advanced rectal cancer.
@en
P2093
Dirk Arnold
Erik Engel
Florian Würschmidt
Jürgen Dunst
Kathrin Dellas
Michael Richter
Thomas Höhler
Thomas Reese
Wolfgang Wagner
P2860
P2888
P356
10.1186/1748-717X-8-90
P50
P577
2013-04-15T00:00:00Z
P6179
1020342618